Search research articles
Contact Us
Filters
Showing results (221-230 of 244) with videos related to
Page
of 25
Sort By:
Life Sciences
|
August 1, 1977
Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors
J Costentin, H Marçais, P Protais, et al.
British Journal of Pharmacology
|
June 1, 1994
The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes
I Dubuc, J Costentin, J P Terranova, et al.
European Journal of Pharmacology
|
July 20, 1984
Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes
M C Fournie-Zaluski, P Chaillet, R Bouboutou, et al.
Journal of Medicinal Chemistry
|
September 1, 1985
New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties
M C Fournié-Zaluski, A Coulaud, R Bouboutou, et al.
Neuroscience Letters
|
August 17, 1992
Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamus
P Kitabgi, I Dubuc, D Nouel, et al.
Life Sciences
|
October 18, 1982
New enkephalinase inhibitors as probes to differentiate "enkephalinase" and angiotensin-converting-enzyme active sites
B P Roques, M C Fournié-Zaluski, D Florentin, et al.
Life Sciences
|
October 18, 1982
Selective participation of both "enkephalinase" and aminopeptidase activities in the metabolism of endogenous enkephalins
S de la Baume, C Gros, C C Yi, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
August 9, 2005
Novel endomorphin-2 analogs with mu-opioid receptor antagonist activity
R Kruszynski, J Fichna, J-C do-Rego, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1986
Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor
J M Lecomte, J Costentin, A Vlaiculescu, et al.
L'Encephale
|
June 3, 2008
[Present data and treatment schedule of aripiprazole in the treatment of schizophrenia]
F Limosin, J M Azorin, M O Krebs, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 244) with videos related to
Sort By:
Page
of 25
Life Sciences
|
August 1, 1977
Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors
J Costentin, H Marçais, P Protais, et al.
British Journal of Pharmacology
|
June 1, 1994
The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes
I Dubuc, J Costentin, J P Terranova, et al.
European Journal of Pharmacology
|
July 20, 1984
Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes
M C Fournie-Zaluski, P Chaillet, R Bouboutou, et al.
Journal of Medicinal Chemistry
|
September 1, 1985
New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties
M C Fournié-Zaluski, A Coulaud, R Bouboutou, et al.
Neuroscience Letters
|
August 17, 1992
Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamus
P Kitabgi, I Dubuc, D Nouel, et al.
Life Sciences
|
October 18, 1982
New enkephalinase inhibitors as probes to differentiate "enkephalinase" and angiotensin-converting-enzyme active sites
B P Roques, M C Fournié-Zaluski, D Florentin, et al.
Life Sciences
|
October 18, 1982
Selective participation of both "enkephalinase" and aminopeptidase activities in the metabolism of endogenous enkephalins
S de la Baume, C Gros, C C Yi, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
August 9, 2005
Novel endomorphin-2 analogs with mu-opioid receptor antagonist activity
R Kruszynski, J Fichna, J-C do-Rego, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1986
Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor
J M Lecomte, J Costentin, A Vlaiculescu, et al.
L'Encephale
|
June 3, 2008
[Present data and treatment schedule of aripiprazole in the treatment of schizophrenia]
F Limosin, J M Azorin, M O Krebs, et al.
Page
of 25